Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
32.32
-0.37 (-1.13%)
Feb 21, 2025, 4:00 PM EST - Market closed
Ionis Pharmaceuticals Revenue by Segment
History
| Date | Research and Development | Commercial |
|---|---|---|
| Dec 31, 2024 | 412.20M | 293.36M |
| Sep 30, 2024 | 517.20M | 286.36M |
| Jun 30, 2024 | 519.24M | 294.71M |
| Mar 31, 2024 | 476.54M | 300.57M |
| Dec 31, 2023 | 479.40M | 308.75M |
| Sep 30, 2023 | 305.40M | 309.75M |
| Jun 30, 2023 | 332.63M | 298.08M |
| Mar 31, 2023 | 277.72M | 298.36M |
| Dec 31, 2022 | 284.60M | 302.88M |
| Sep 30, 2022 | 565.60M | 309.88M |
| Jun 30, 2022 | 526.51M | 322.29M |
| Mar 31, 2022 | 510.80M | 329.97M |
| Dec 31, 2021 | 468.32M | 342.13M |
| Sep 30, 2021 | 309.32M | 351.13M |
| Jun 30, 2021 | 326.05M | 361.31M |
| Mar 31, 2021 | 342.16M | 365.45M |
| Dec 31, 2020 | 364.00M | 365.00M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.